Clinical Trials Sponsored by National Psoriasis Foundation

Total 2370 results

Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Recurrent Ovarian Carcinoma | Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Terminated

AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer

Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Recurrent Cervical Carcinoma

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva

Stage III Vulvar Cancer | Stage IVB Vulvar Cancer | Vulvar Squamous Cell Carcinoma

United States
Beijing Anzhen Hospital
National Natural Science Foundation of China

Completed

Corticosteroid Prophylaxis on the Cardiopulmonary Bypass-Induced Systemic Inflammatory Response

Systemic Inflammatory Response Syndrome | Heart Valve Diseases

China
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission

Stage IIA Fallopian Tube Cancer | Stage IIA Ovarian Cancer | Stage IIB Fallopian Tube Cancer | Stage IIB Ovarian Cancer | Stage IIC Fallopian Tube Cancer | Stage IIC Ovarian Cancer | Stage IIIA Fallopian Tube Cancer | Stage IIIA Ovarian Cancer | Stage IIIA Primary Peritoneal Cancer | Stage IIIB Fallopian... and other conditions

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer

Recurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Endometrial Adenosquamous Carcinoma | Endometrial Mixed Adenocarcinoma | Stage IIIA Uterine Corpus Cancer | Stage IIIC Uterine Corpus Cancer | Stage... and other conditions

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Second Curettage in Treating Patients With Persistent Non-metastatic Gestational Trophoblastic Tumors

Non-Metastatic Gestational Trophoblastic Tumor | Complete Hydatidiform Mole | Partial Hydatidiform Mole

United States, Canada
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Prognostic Biomarkers in Patients With Endometrial Cancer

Recurrent Uterine Corpus Carcinoma | Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage IV Uterine Corpus Cancer | Endometrial Adenocarcinoma

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Withdrawn

Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line Chemotherapy

Recurrent Ovarian Carcinoma | Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Stage IV Ovarian Cancer | Stage III Ovarian Cancer

United States
University of California, Davis
The National Fragile X Foundation

Completed

Trial of Minocycline to Treat Children With Fragile X Syndrome

Fragile X Syndrome

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Unknown

Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer (LEG)

Lymphedema | Stage II Uterine Corpus Cancer | Stage IVB Vulvar Cancer | Stage IA Uterine Corpus Cancer | Stage IB Uterine Corpus Cancer | Stage IA Cervical Cancer | Stage IB Cervical Cancer | Stage II Vulvar Cancer | Stage IIA Cervical Cancer | Stage IA Vulvar Cancer | Stage IB Vulvar Cancer | Stage IIIA Vulvar... and other conditions

United States
Mudanjiang Medical University
National Natural Science Foundation of China

Unknown

Magnetic Resonance Imaging-based Comparative Research in Different Mild Cognitive Impairment Subtype

Mild Cognitive Impairment

China
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus

Recurrent Uterine Corpus Sarcoma | Uterine Corpus Leiomyosarcoma

United States
Royal Marsden NHS Foundation Trust

Completed

Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer

Sarcoma | Cervical Cancer | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Fallopian Tube Cancer | Vulvar Cancer | Endometrial Cancer | Vaginal Cancer | Adenocarcinoma of the Gastroesophageal Junction

United Kingdom
Royal Marsden NHS Foundation Trust

Completed

Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal Cancer

Sarcoma | Cervical Cancer | Colorectal Cancer | Ovarian Cancer | Fallopian Tube Cancer | Bladder Cancer | Anal Cancer | Radiation Toxicity | Gastrointestinal Complications

United Kingdom
Adrian Guggisberg
Swiss National Science Foundation

Completed

Randomized Trial of Transcranial Theta-burst Stimulation and Transcranial Direct Current Stimulation

Stroke

Switzerland
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus

Recurrent Uterine Corpus Carcinoma | Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage IV Uterine Corpus Cancer | Endometrial Adenocarcinoma | Endometrial Adenosquamous Carcinoma | Endometrial Endometrioid Adenocarcinoma, Variant With Squamous...

United States
National Center for Telehealth and Technology
The Geneva Foundation

Completed

Comparing Virtual Reality Exposure Therapy to Prolonged Exposure (VRPE Extension)

Post-Traumatic Stress Disorder | Stress Disorders

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Withdrawn

Research Study in Patients With Advanced Ovarian Epithelial Cancer

Ovarian Serous Cystadenocarcinoma | Stage IIIA Ovarian Cancer | Stage IIIB Ovarian Cancer | Stage IIIC Ovarian Cancer | Stage IV Ovarian Cancer | Ovarian Serous Surface Papillary Adenocarcinoma

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva

Vulvar Cancer

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer

Precancerous Condition | Stage 0 Cervical Cancer

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer

Cervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma | Recurrent Cervical Carcinoma | Cervical Small Cell Carcinoma

United States, Spain
Zurich University of Applied Sciences
Swiss National Science Foundation

Completed

Mobility Enhancing Nursing Intervention (MFP)

Stroke | Multiple Sclerosis

Switzerland
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer

Endometrial Cancer | Psychosocial Effects of Cancer and Its Treatment

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix

Cervical Cancer

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)

Endometrial Cancer

United States, Norway, Canada, Australia, Japan
Dr. Susan Love Research Foundation

Unknown

Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery

Breast Cancer

United States
Royal Marsden NHS Foundation Trust

Completed

Vitamin E and Pentoxifylline in Treating Women With Lymphedema After Radiation Therapy for Breast Cancer

Breast Cancer | Lymphedema

United Kingdom
Royal Marsden NHS Foundation Trust

Completed

Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer

Head and Neck Cancer | Radiation Toxicity | Oral Complications

United Kingdom
The Christie NHS Foundation Trust

Unknown

Gemcitabine Plus Supportive Care in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Lung Cancer

United Kingdom
The Christie NHS Foundation Trust

Unknown

Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin

Carcinoma of Unknown Primary

United Kingdom
The Christie NHS Foundation Trust

Unknown

Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer

Sarcoma | Cervical Cancer | Breast Cancer | Ovarian Cancer | Fallopian Tube Cancer | Prostate Cancer | Vulvar Cancer | Endometrial Cancer | Vaginal Cancer | Primary Peritoneal Cavity Cancer

United Kingdom
Royal Marsden NHS Foundation Trust

Unknown

Intensity-Modulated Radiation Therapy in Treating Patients With Prostate Cancer

Prostate Cancer

United Kingdom
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

Endometrial Cancer

United States, Canada
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer

Unspecified Adult Solid Tumor, Protocol Specific | Gestational Trophoblastic Tumor | Neurotoxicity | Peripheral Neuropathy

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Terminated

Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus

Sarcoma

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Liposomal Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer

Ovarian Cancer

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Withdrawn

Nitrocamptothecin in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer

Ovarian Cancer | Primary Peritoneal Cavity Cancer
Gynecologic Oncology Group
National Cancer Institute (NCI)

Terminated

Paclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer

Ovarian Cancer | Primary Peritoneal Cavity Cancer

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Vulva

Lymphedema | Vulvar Cancer | Perioperative/Postoperative Complications

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix

Cervical Cancer

United States, Canada
The Christie NHS Foundation Trust

Completed

Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery

Pancreatic Cancer

United Kingdom
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic Neoplasia

Gestational Trophoblastic Tumor

United States, Norway
Gynecologic Oncology Group
National Cancer Institute (NCI)

Terminated

Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk

Ovarian Cancer

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Withdrawn

Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or Carboplatin

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Chemotherapy in Treating Patients With Sarcoma of the Uterus

Sarcoma | Endometrial Cancer

United States, Canada
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer

Cervical Cancer

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Cervical Cancer

United States, Norway

Clinical Trials Sponsored by National Psoriasis Foundation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Montenegro

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations